NCT06779682

Brief Summary

The goal of this observational study is to evaluate the feasibility of a systematic screening protocol for Obstructive Sleep Apnea (OSA) during preoperative anesthesia consultations in adults aged 50 and older undergoing elective surgery. The main questions it aims to answer are:

  • Does the systematic screening protocol increase the proportion of patients identified as being at high risk for OSA compared to standard care?
  • What is the impact of systematic screening on postoperative outcomes, including complications, length of stay, and mortality? Researchers will compare standard care practices (before implementation) to the systematic screening protocol (after implementation) to determine the effect on OSA detection rates and clinical outcomes. Participants will:
  • Complete the STOP-BANG questionnaire during their anesthesia consultation.
  • (Optional) Have a facial photograph taken to analyze morphometric characteristics that may correlate with OSA risk.
  • Be referred for further diagnostic testing if identified as high-risk for OSA.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 13, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 16, 2025

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 17, 2025

Status Verified

January 1, 2025

Enrollment Period

Same day

First QC Date

January 13, 2025

Last Update Submit

January 16, 2025

Conditions

Keywords

preoperativeSTOP-BANG scoreObstructive Sleep ApneaAIOSA

Outcome Measures

Primary Outcomes (1)

  • proportion of participants in whom the risk of OSA (Obstructive Sleep Apnea Syndrome) was detected in the control group before versus the group after

    From enrollment to the end of treatment at 7 months

Secondary Outcomes (6)

  • Mortality at 3 months.

    From enrollment to the end of treatment at 7 months

  • Postoperative length of stay.

    From enrollment to the end of treatment at 7 months

  • Sensitivity, specificity, and concordance rate of OSA (Obstructive Sleep Apnea Syndrome) detection.

    From enrollment to the end of treatment at 7 months

  • Correlation between facial morphotype and OSA diagnosis with and without facial morphotype measurement.

    From enrollment to the end of treatment at 7 months

  • Postoperative complications and mortality at 3 months.

    From enrollment to the end of treatment at 7 months

  • +1 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with a STOP BANG \> 5 or \> 4 associated with an obesity (BMI \> 35 kg/m2)

You may qualify if:

  • All patients with a national health identifier affiliated with the social security system, aged over 18, including French individuals over 50 years old, in scheduled anesthesia consultation with STOP BANG \> 5 or \> 4 with BMI \> 35

You may not qualify if:

  • Refusal to participate in the study, age under 50, not affiliated with the social security system, minor or under legal protection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Privé Claude Galien

Quincy-sous-Sénart, 91480, France

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2025

First Posted

January 16, 2025

Study Start

December 1, 2024

Primary Completion

December 1, 2024

Study Completion

September 1, 2025

Last Updated

January 17, 2025

Record last verified: 2025-01

Locations